Andlauer Healthcare Group Inc. (TSE:AND) to Issue Quarterly Dividend of $0.08

Andlauer Healthcare Group Inc. (TSE:AND – Get Rating) declared a quarterly dividend on Wednesday, March 15th, Zacks reports. Stockholders of record on Friday, March 31st will be given a dividend of 0.08 per share on Monday, April 17th. This represents a $0.32 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, March 30th. This is a boost from Andlauer Healthcare Group’s previous quarterly dividend of $0.07.

Andlauer Healthcare Group Trading Up 1.5 %

AND opened at C$46.51 on Friday. The stock has a market capitalization of C$933.46 million, a P/E ratio of 25.98 and a beta of 0.66. The company has a current ratio of 2.01, a quick ratio of 1.66 and a debt-to-equity ratio of 37.03. Andlauer Healthcare Group has a 12 month low of C$37.57 and a 12 month high of C$55.97. The firm’s fifty day simple moving average is C$47.17 and its 200 day simple moving average is C$48.99.

Andlauer Healthcare Group (TSE:AND – Get Rating) last released its quarterly earnings results on Thursday, March 2nd. The company reported C$0.46 earnings per share (EPS) for the quarter. The firm had revenue of C$165.77 million for the quarter. Andlauer Healthcare Group had a return on equity of 19.23% and a net margin of 11.76%. As a group, research analysts anticipate that Andlauer Healthcare Group will post 1.7904762 EPS for the current fiscal year.

Insider Activity

In other news, Senior Officer Stephen Barr sold 5,000 shares of the company’s stock in a transaction dated Thursday, December 29th. The shares were sold at an average price of C$48.50, for a total value of C$242,500.00. Following the sale, the insider now directly owns 20,498 shares of the company’s stock, valued at approximately C$994,153. Insiders own 1.82% of the company’s stock.

Analysts Set New Price Targets

AND has been the topic of several research reports. Eight Capital set a C$62.00 target price on Andlauer Healthcare Group and gave the company a “buy” rating in a research note on Tuesday, January 17th. CIBC reduced their target price on shares of Andlauer Healthcare Group from C$59.00 to C$54.00 and set a “neutral” rating for the company in a report on Wednesday, January 18th. Royal Bank of Canada boosted their price target on shares of Andlauer Healthcare Group from C$47.00 to C$48.00 and gave the stock a “sector perform” rating in a research report on Monday, March 6th. Scotiabank raised their price objective on Andlauer Healthcare Group from C$53.00 to C$55.00 in a report on Monday, January 23rd. Finally, TD Securities lifted their target price on Andlauer Healthcare Group from C$57.00 to C$58.00 and gave the company a “hold” rating in a research report on Monday, March 6th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of C$57.43.

Andlauer Healthcare Group Company Profile

(Get Rating)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.